Work

Updated patent review for hematopoietic progenitor kinase (HPK1) inhibitors and degraders (2021-present)

Year: 2025

Type: review

Source: Expert Opinion on Therapeutic Patents

DOI: 10.1080/13543776.2025.2462834

Authors: Ying-Hui Yuan, Jia-Ying Mao, Ji-Fan Yue, Meng-Lan He, Zi Hui, Hang Yin, Jianshe Wang, Xiang-Yang Ye

Institutions: Hangzhou Normal University, Tsinghua University, Zhejiang Yongning Pharma (China)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Hangzhou Normal University

OpenAlex ID: W4407592976

FWCI: 0.352

Cites: 31

Cited by: 4

Related to: 10